Experts recommend Covaxin for phase 2/3 trials on those aged 2-18 year

Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said

from Latest News https://ift.tt/2QbCaFN
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share